When will gynecologists be able to get rid of cervical cancer?

The first-of-its-kind study will help the gynecological community better understand how cervical cancer treatments and surgeries work, according to the Mayo Clinic.

The new study is the result of a collaboration between Mayo Clinic researchers and researchers at the University of Wisconsin, Madison.

The researchers have developed a new way of measuring how much cervical cancer cells are removed from a woman’s cervical lining during an initial procedure called cervical ablation.

They then monitored the cells after the procedure.

In addition to measuring the cells removed, the study also looked at the number of cervical cells remaining in the cervical sac after the cervical abrasion.

The results showed that the cells that were removed from the cervical lining and in the sac before the ablation were about one-third the size they would be if the cells were removed immediately after the surgery.

It also showed that more cells remained in the cells immediately after ablation than after abrading them.

A second group of researchers will study whether the study findings can be used to predict the effectiveness of various types of cervical ablated surgery, such as cervical abutment.

Both groups will study how the cells in the cervix are removed during these types of surgeries.

The Mayo researchers have also created a tool called the Cellular DNA Sequencing (CDS) system that can identify cells in a cervical sac and identify the types of cells removed from them.

Researchers hope to have the system ready to be used in the future for the first time in women with cervical cancer, Dr. Daniel S. Reischauer, director of the Mayo Cancer Center’s Division of Cancer Prevention and Control, said in a news release.

The study is published in the Journal of Gynecological Science.

The results of the study were significant, said Dr. David G. Johnson, an endocrinologist and the study’s senior author.

They showed that cervical cells can survive ablation for up to 12 months and can return to their normal size after ablating.

He also noted that the researchers found that ablation did not affect the cells’ ability to regenerate and could help to reduce the risk of cervical cancers spreading.

The research was funded by the National Institutes of Health (grant R01 CA084579) and the Mayo Foundation.